TWO SIGMA INVESTMENTS, LP - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$236,282
-87.4%
7,400
-87.9%
0.00%
-80.0%
Q1 2023$1,877,006
-80.2%
61,300
-69.2%
0.01%
-84.4%
Q3 2022$9,480,000
+559.7%
198,996
+436.1%
0.03%
+540.0%
Q2 2022$1,437,000
-64.0%
37,118
-46.7%
0.01%
-58.3%
Q1 2022$3,987,000
+105.3%
69,580
+185.6%
0.01%
+200.0%
Q4 2021$1,942,000
-89.7%
24,366
-88.7%
0.00%
-90.5%
Q3 2021$18,768,000
-13.0%
215,697
+28.7%
0.04%
-14.3%
Q2 2021$21,572,000
+691.1%
167,601
+391.8%
0.05%
+600.0%
Q1 2021$2,727,00034,0760.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders